These data indicate that FAK and c-Myc synergistically drive tumor cell survival largely by decreasing the cellular level of Bim or the ratios of Bim/Bcl2 + Bcl-xl, regardless the endogenous level of Bim. The gene discussed is PTK2; the disease is neoplasm.